Aimovig (erenumab) is a monoclonal antibody that blocks the activation of a certain protein that can produce a migraine attack. This protein, called calcitonin gene- related peptide (CGRP), can cause blood vessels to dilate and cause inflammation and migraine headache pain.
Aimovig is a prescription medicine used for the preventive treatment of migraine in adults.
Aimovig may also be used for purposes not listed in this medication guide.
